| 000 | 01466 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514034652.0 | ||
| 264 | 0 | _c20030213 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a0724-8741 | ||
| 024 | 7 |
_a10.1023/a:1015318415705 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBartsch, Martin | |
| 245 | 0 | 0 |
_aMassive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells. _h[electronic resource] |
| 260 |
_bPharmaceutical research _cMay 2002 |
||
| 300 |
_a676-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAconitic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 |
_aEndothelium _xcytology |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xgenetics |
| 650 | 0 | 4 | _aLipids |
| 650 | 0 | 4 |
_aLiver _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSerum Albumin _xchemistry |
| 650 | 0 | 4 | _aSerum Albumin, Human |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aWeeke-Klimp, Alida H | |
| 700 | 1 | _aMeijer, Dirk K F | |
| 700 | 1 | _aScherphof, Gerrit L | |
| 700 | 1 | _aKamps, Jan A A M | |
| 773 | 0 |
_tPharmaceutical research _gvol. 19 _gno. 5 _gp. 676-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1015318415705 _zAvailable from publisher's website |
| 999 |
_c11964364 _d11964364 |
||